S'abonner

Dermoscopy report: Proposal for standardization : Results of a consensus meeting of the International Dermoscopy Society - 19/08/11

Doi : 10.1016/j.jaad.2006.02.051 
Josep Malvehy, MD a, , Susana Puig, MD a, Giuseppe Argenziano, MD b, Ashfaq A. Marghoob, MD c, H. Peter Soyer, MD d

on behalf of the International Dermoscopy Society Board members

  Board Members of the International Dermoscopy Society: R. Anadolu (Turkey), L. Andreassi (Italy); I. Bartenjev (Slovenia); R. Bergman (Israel); M. Binder (Austria); A. Blum (Germany); J. Bowling (United Kingdom), R. Braun (Switzerland); H. Cabo (Argentina); L. Cabrijan (Croatia); P. Carli (Italy); B. Carlos (Mexico); S. Chimenti (Italy); A. B. Cognetta (United States); R. Corona (Italy); V. De Giorgi (Italy); H. Dong (China); G. Ferrara (Italy); M. Fleming (United States); J. Grichnik (United States); C. Grin-Jorgensen (United States); A. Halpern (United States), R. Hofmann-Wellenhof (Austria); C. Ingvar (Sweden); R. Johr (United States), B. Katz (United States), H. Kerl (Austria); H. Kittler (Austria); A. W. Kopf (United States); J. Kreusch (Germany); D. Langford (New Zealand); B. Li (China); H. Lorentzen (Denmark); A. A. Marghoob (United States); C. Massone (Austria); G. Mazzocchetti (Italy); W. McCarthy (Australia); S. Menzies (Australia); M. Oliviero (United States), F. Özdemir (Turkey); H. Pehamberger (Austria); G. Pellacani (Italy); K. Peris (Italy); A. Perusquia (Mexico); D. Piccolo (Italy); M. A. Pizzichetta (Italy); D. Polsky (United States); H. Rabinovitz (United States), B. Rao (United States); S. Ronger (France); P. Rubegni (Italy); T. Saida (Japan); M. Scalvenzi (Italy); R. Schiffner (Germany); S. Seidenari (Italy); I. Stanganelli (Italy); W. V. Stoecker (United States); W. Stolz (Germany); M. Tanaka (Japan); L. Thomas (France); T. Tsuchida (Japan); S. Q. Wang (United States); K. Westerhoff (Sweden); I. H. Wolf (Austria); I. Zalaudek (Austria).

a From the Dermatology Department, Melanoma Unit, Hospital Clinic, Barcelona 
b Dermatology Department, Second University of Naples 
c Memorial Sloan-Kettering Cancer Center, New York 
d Department of Dermatology, University of Graz 

Reprint requests: Josep Malvehy, MD, Department of Dermatology, Hospital Clinic, C/Villarroel 170, 08036 Barcelona, Spain.

Barcelona, Spain; Naples, Italy; New York, New York; and Graz, Austria

Abstract

Background

Dermoscopy can assist clinicians in the evaluation and diagnosis of skin tumors. Since dermoscopy is becoming widely accepted and used in the medical community, there is now the need for a standardized method for documenting dermoscopic findings so as to be able to effectively communicate such information among colleagues.

Objectives

Toward this end, the International Dermoscopy Society embarked on creating a consensus document for the standardization and recommended criteria necessary to be able to effectively convey dermoscopic findings to consulting physicians and colleagues.

Methods

The Dermoscopy Report Steering Committee created an extensive list of dermoscopic criteria obtained from an exhaustive search of the literature. A preliminary document listing all the dermoscopic criteria that could potentially be included in a standardized dermoscopy report was elaborated and presented to the members of the International Dermoscopy Society Board in two meetings of the Society and subsequently discussed via Internet communications between members and the Steering Committee.

Results

A consensus document including 10 points categorized as either recommended or optional and a template of the dermoscopy report were obtained. The final items included in the document are as follows: (1) patient’s age, relevant history pertaining to the lesion, pertinent personal and family history (recommended); (2) clinical description of the lesion (recommended); (3) the two-step method of dermoscopy differentiating melanocytic from nonmelanocytic tumors (recommended); (4) the use of standardized terms to describe structures as defined by the Dermoscopy Consensus Report published in 2003. For new terms it would be helpful to provide a working definition (recommended); (5) the dermoscopic algorithm used should be mentioned (optional); (6) information on the imaging equipment and magnification (recommended); (7) clinical and dermoscopic images of the tumor (recommended); (8) a diagnosis or differential diagnosis (recommended); (9) decision concerning the management (recommended); (10) specific comments for the pathologist when excision and histopathologic examination are recommended (optional).

Limitations

The limitations of this study are those that are intrinsic of a consensus document obtained from critical review of the literature and discussion by opinion leaders in the field.

Conclusions

Although it may be acceptable for a consulting physician to only state the dermoscopic diagnosis, the proposed standardized reporting system, if accepted and utilized, will make it easier for consultants to communicate with each other more effectively.

Le texte complet de cet article est disponible en PDF.

Plan


 Funding sources: None.
Conflicts of interest: None declared.


© 2007  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 57 - N° 1

P. 84-95 - juillet 2007 Retour au numéro
Article précédent Article précédent
  • Adherence to topical therapy increases around the time of office visits
  • Steven R. Feldman, Fabian T. Camacho, Jennifer Krejci-Manwaring, Christie L. Carroll, Rajesh Balkrishnan
| Article suivant Article suivant
  • Diving into the blue: In vivo microscopic characterization of the dermoscopic blue hue
  • Giovanni Pellacani, Sara Bassoli, Caterina Longo, Anna Maria Cesinaro, Stefania Seidenari

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.